Back to Search
ROBERT SHARKEY, PH.D.
PH.D.
Mental Health Counselor
NPI: 1912009895Individual
Specialties, Licenses & Credentials
Mental Health CounselorPrimary
Counselor — Mental Health
Code: 101YM0800X
6301007763(MI)
Research & Publications (20)
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy.
PMID 19182204·Blood·2009
7-preclinical
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
PMID 19223402·J Nucl Med·2009
4-observational
Embolisation of vegetation to the liver in right sided infective endocarditis.
PMID 19327593·Eur J Intern Med·2009
5-case
Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody cap.
PMID 19409040·Cancer Biother Radiopharm·2009
8-other
Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab).
PMID 18829494·Clin Cancer Res·2008
7-preclinical
Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting.
PMID 18077530·J Nucl Med·2008
6-review
Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model.
PMID 18227543·Radiology·2008
7-preclinical
Use of antibodies and immunoconjugates for the therapy of more accessible cancers.
PMID 18508155·Adv Drug Deliv Rev·2008
6-review
Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody.
PMID 18593929·Cancer Res·2008
7-preclinical
Novel radioimmunopharmaceuticals for cancer imaging and therapy.
PMID 19037837·Curr Opin Investig Drugs·2008
6-review
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
PMID 18559529·Cancer Res·2008
7-preclinical
Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update.
PMID 17875792·Clin Cancer Res·2007
6-review
A divalent hapten-peptide induces apoptosis in human non hodgkin lymphoma cell lines targeted by anti-CD20xanti-hapten bispecific antibodies.
PMID 17875790·Clin Cancer Res·2007
8-other
Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.
PMID 18311322·Update Cancer Ther·2007
8-other
Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumors.
PMID 17000696·Clin Cancer Res·2006
4-observational
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.
PMID 17015905·J Nucl Med·2006
7-preclinical
Advances in cancer therapy with radiolabeled monoclonal antibodies.
PMID 17043623·Q J Nucl Med Mol Imaging·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 56730 CALUMET AVE STE F
CALUMET, MI 49913 - Phone
- (906) 337-6839
Quick Facts
- NPI
- 1912009895
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile